ReciBioPharm vs Richter BioLogics: CDMO Comparison

Side-by-side comparison of ReciBioPharm and Richter BioLogics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Keele, UK · Sodertalje, SE
Signal Score
88/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
3
Clinical programs (matched)
0
Capacity
—
Modalities
AAV, Lentiviral, Plasmid, mRNA
Hamburg, Germany
Signal Score
83/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
9
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
—
Modalities
Plasmid DNA, Recombinant Proteins, VHH/Nanobodies, Bacterial Vaccines, Biologics

Key differences

  • Richter BioLogics holds 9 active EMA GMP certificates; ReciBioPharm does not appear in EudraGMDP.
  • ReciBioPharm maintains 3 MHRA / UK GMP certificates; Richter BioLogics does not.

On a 13-modality CDMO landscape, both ReciBioPharm and Richter BioLogics qualify as Plasmid DNA manufacturers; ReciBioPharm carries the higher composite Signal Score for Plasmid DNA programs in this comparison.

What to evaluate for Plasmid DNA programs

Both ReciBioPharm and Richter BioLogics qualify as Plasmid DNA CDMOs. When choosing between them for Plasmid DNA programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

GMP grade & purity

Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.

Fermentation scale & yield

Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.

Lead time

Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.

Regulatory track record

Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.

See all Plasmid DNA CDMOs ranked by Signal Score →

Frequently asked: ReciBioPharm vs Richter BioLogics

How do ReciBioPharm and Richter BioLogics compare on European GMP coverage?

ReciBioPharm holds 0 active EMA GMP certificates and 3 MHRA / UK certificates. Richter BioLogics holds 9 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is better for Plasmid DNA manufacturing — ReciBioPharm or Richter BioLogics?

Both ReciBioPharm and Richter BioLogics are tagged as Plasmid DNA CDMOs in our directory, so both are credible options for Plasmid DNA programs. The most important differentiator for Plasmid DNA selection is typically gmp grade & purity: Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

ReciBioPharm carries a Signal Score of 88/100 and Richter BioLogics carries 83/100 — a small lead for ReciBioPharm. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

How we score CDMOs →  ·  Compare other CDMOs →

Evaluating ReciBioPharm and Richter BioLogics for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.